Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marciniak

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Adverse effect of heparin on thrombin inactivationE Marciniak
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Physiology of antithrombin IIIE Marciniak
Thrombosis Et Diathesis Haemorrhagica|December 31, 1970
Functional and stric characteristics of modified thrombin zymogenE Marciniak
British Journal of Haematology|June 1, 1981
Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparinE Marciniak
Advances in Experimental Medicine and Biology|January 1, 1987
Genetic coagulation defectsE Marciniak
British Journal of Haematology|March 1, 1973
Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complexE Marciniak
Thrombosis and Haemostasis|August 31, 1977
Antithrombin III and heparin inactivation in thrombin involving reactionsE Marciniak
Blood|March 1, 1982
Differential role of fractionated heparin in antithrombin-III proteolysisE Marciniak
The Journal of Laboratory and Clinical Medicine|September 1, 1974
Binding of heparin in vitro and in vivo to plasma proteinsE Marciniak
The Journal of Laboratory and Clinical Medicine|June 1, 1972
Inhibitor of human blood coagulation elicited by thrombinE Marciniak
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Adverse effect of heparin on thrombin inactivationE Marciniak
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Physiology of antithrombin IIIE Marciniak
Thrombosis Et Diathesis Haemorrhagica|December 31, 1970
Functional and stric characteristics of modified thrombin zymogenE Marciniak
British Journal of Haematology|June 1, 1981
Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparinE Marciniak
Advances in Experimental Medicine and Biology|January 1, 1987
Genetic coagulation defectsE Marciniak
British Journal of Haematology|March 1, 1973
Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complexE Marciniak
Thrombosis and Haemostasis|August 31, 1977
Antithrombin III and heparin inactivation in thrombin involving reactionsE Marciniak
Blood|March 1, 1982
Differential role of fractionated heparin in antithrombin-III proteolysisE Marciniak
The Journal of Laboratory and Clinical Medicine|September 1, 1974
Binding of heparin in vitro and in vivo to plasma proteinsE Marciniak
The Journal of Laboratory and Clinical Medicine|June 1, 1972
Inhibitor of human blood coagulation elicited by thrombinE Marciniak
Pageof 4